J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279 - 14 Feb 2022
Best Paper Award
Dear Colleagues,
We are pleased to announce the winners of the Journal of Personalized Medicine (JPM) 2021 Best Paper Award. All papers published from 1 January 2021 to 31 December 2021 in JPM were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, two winners were selected.
One Review
Breast Cancer Treatments: Updates and New Challenges
By Anna Burguin, Caroline Diorio and Francine Durocher*
J. Pers. Med. 2021, 11(8), 808; doi:10.3390/jpm11080808
One Article
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
By Minghui Li, Jing Yuan, Gang Lv, Jacob Brown, Xiangxiang Jiang and Zhiqiang Kevin Lu*
J. Pers. Med. 2021, 11(11), 1106; doi:10.3390/jpm11111106
Each winner will receive CHF 500 and a chance to publish a paper in JPM in 2023 after peer review.
Please join us in congratulating the winners of the JPM 2021 Best Paper Award. We would also like to take this opportunity to thank all of our authors for their continued support of JPM.
Kind regards,
JPM Editorial Office
JPM 2021 Best Paper Award
Eligibility and Requirements
– All papers published in JPM will be eligible (Both regular and Special Issue submissions).
Past Winners
Year:
Winner
Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions
Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program
J. Pers. Med. 2022, 12(3), 421; https://doi.org/10.3390/jpm12030421 - 8 Mar 2022
Winner
Francine Durocher
1. Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1T 1C2, Canada
2. Cancer Research Center, CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada
Zhiqiang Kevin Lu
College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA
Winner
Molecular and Cellular Mechanisms Affected in ALS
Northern Ireland Center for Stratified/Personalised Medicine, Biomedical Sciences Research Institute, Ulster University, Derry-Londonderry BT47, UK
Postulated Adjuvant Therapeutic Strategies for COVID-19
Fagron. Lichtenauerlaan 182, 3062 Rotterdam, The Netherlands
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
CEINGE—Biotecnologie Avanzate s.c.a.r.l., 80131 Naples, Italy
Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Napoli, Italy
Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pasca
Award Committee
Prof. Dr. Richard E Frye
Chairman
Autism Discovery and Treatment Foundation
Winner
S. Pamela K. Shiao
College of Nursing and Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
paper link: https://www.mdpi.com/2075-4426/8/1/10
